Burnet Institute Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2012
NCT02698098
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Burnet Institute | Macfarlane Burnet Institute for Medical Research and Public Health Ltd